Voyager Therapeutics (VYGR) Short-term Investments (2015 - 2026)

Voyager Therapeutics has reported Short-term Investments for 12 years, with the latest figure at $98.2 million in Q1 2026.

• Quarterly Short-term Investments fell 39.13% year-over-year to $98.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.2 million (down 39.13% YoY) and the FY2025 annual result came in at $131.1 million, down 32.85% from the prior year.
• Short-term Investments fell to $98.2 million in Q1 2026 per VYGR's latest filing, from $131.1 million in the prior quarter.
• Over five years, Short-term Investments peaked at $294.9 million in Q2 2024 and troughed at $5.0 million in Q1 2023.
• A 5-year average of $132.2 million and a median of $161.3 million in 2025 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments slumped 85.72% in 2023, then surged 5036.99% in 2024.
• Over 5 years, Short-term Investments stood at $19.9 million in 2022, then surged by 714.89% to $162.1 million in 2023, then gained by 20.51% to $195.3 million in 2024, then sank by 32.85% to $131.1 million in 2025, then declined by 25.15% to $98.2 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $98.2 million, $131.1 million, and $163.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.